Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Norton Pulmonary Specialists Pulmonary Hypertension Center is a specialized clinical and research facility based in Louisville, Kentucky, operating as part of the Norton Healthcare system. The center is recognized as a Pulmonary Hypertension Association (PHA) Accredited Center of Excellence, a designation reserved for programs that demonstrate high-quality care and specialized expertise in managing complex pulmonary vascular diseases. It provides comprehensive diagnostic services, including right heart catheterization and advanced imaging, alongside a multidisciplinary approach to treatment. As a regional leader in clinical research, the center actively participates in Phase 2 and Phase 3 clinical trials, offering patients access to novel therapeutic agents for pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH). The facility integrates specialized nursing, pharmacy support, and physician expertise to manage advanced therapies such as continuous intravenous and subcutaneous prostanoids.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Norton Pulmonary Specialists Pulmonary Hypertension Center.